Measurement of apoptosis in cytological specimens by flow cytometry: Comparison of Annexin V, caspase cleavage and dUTP incorporation assays

Cytopathology

Volumn 22, Issue 6, 2011, Pages 365-372

  Dong, H P ^a   Holth, A ^a   Ruud, M G ^a   Emilsen, E ^a   Risberg, B ^a   Davidson, B ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Annexin V; Apoptosis; Caspase; DUTP incorporation; Fine needle aspiration cytology; Flow cytometry; Metastatic carcinoma; Reactive mesothelial cells; Serous effusions

Indexed keywords

CASPASE 3; CASPASE 8; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; ASPIRATION CYTOLOGY; CELL ASSAY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANNEXIN A5; APOPTOSIS; ASCITIC FLUID; BIOPSY, FINE-NEEDLE; CASPASES; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; NEOPLASM METASTASIS; PLEURAL EFFUSION;

EID: 81355147113     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2010.00811.x     Document Type: Article

References (47)

1. Vermeulen K, Van bockstaele DR, Berneman ZN. Apoptosis: mechanisms and relevance in cancer. Ann Hematol 2005;84:627-39.
2. Fadeel B, Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 2005;258:479-517.
3. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
4. Viktorsson K, Lewensohn R, Zhivotovsky B. Apoptotic pathways and therapy resistance in human malignancies. Adv Cancer Res 2005;94:143-96.
5. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009;361:1570-83.
6. Dong HP, Holth A, Berner A, Davidson B, Risberg B. Flow cytometric immunphenotyping of epithelial cancer cells in effusions-Technical considerations and pitfalls. Cytometry B Clin Cytom 2007;72B:332-43.
7. Homburg CH, de Haas M, von dem Borne AE et al. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin-V binding sites during apoptosis in vitro. Blood 1995;85:532-40.
8. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin-V. J Immunol Methods 1995;184:39-51.
9. van Engeland M, Ramaekers FC, Schutte B, Reutelingsperger CP. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996;24:131-9.
10. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin-V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998;31:1-9.
11. Troiano L, Ferraresi R, Lugli E et al. Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry. Nat Protoc 2007;2:2719-27.
12. Ormerod MG, Paul F, Cheetham M, Sun XM. Discrimination of apoptotic thymocytes by forward light scatter. Cytometry 1995;21:300-4.
13. Schmid I, Uittenbogaart C, Jamieson BD. Live-cell assay for detection of apoptosis by dual-laser flow cytometry using Hoechst 33342 and 7-amino-actinomycin D. Nat Protoc 2007;2:187-90.
14. Belloc F, Belaud-Rotureau MA, Lavignolle V et al. Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells. Cytometry 2000;40:151-60.
15. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993;53:1945-51.
16. Dong HP, Kleinberg L, Davidson B, Risberg B. Methods for simultaneous measurement of apoptosis and cell surface phenotype of epithelial cells in effusions by flow cytometry. Nat Protoc 2008;3:955-64.
17. Kleinberg L, Dong HP, Holth A et al. Cleaved caspases and NF-κB p65 are prognostic factors in metastatic ovarian carcinoma. Hum Pathol 2009;40:795-806.
18. Dong HP, Holth A, Kleinberg L et al. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the Annexin-V/7-AAD assay - Clinical relevance and comparison to other apoptosis parameters. Am J Clin Pathol 2009;132:756-62.
19. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990;136:593-608.
20. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
21. Gorczyca W, Bigman K, Mittelman A et al. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 1993;7:659-70.
22. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21:485-95.
23. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008;9:231-41.
24. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002;2:277-88.
25. Martin SJ, Reutelingsperger CP, McGahon AJ et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-56.
26. Andree HA, Reutelingsperger CP, Hauptmann R et al. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990;265:4923-8.
27. Koopman G, Reutingsperger CP, Kuijten GA et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-20.
28. Pozarowski P, Grabarek J, Darzynkiewicz Z. Flow cytometry of apoptosis. Curr Protoc Cell Biol 2004; Chapter 18:Unit 18.8.
29. Davidson B, Nielsen S, Christensen J et al. The role of Desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001;25:1405-12.
30. Pepper C, Thomas A, Tucker H, Hoy T, Bentley P. Flow cytometric assessment of three different methods for the measurement of in vitro apoptosis. Leuk Res 1998;22:439-44.
31. Hammill AK, Uhr JW, Scheuermann RH. Annexin-V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 1999;251:16-21.
32. Yang MY, Chuang H, Chen RF, Yang KD. Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks. J Leukoc Biol 2002;71:231-7.
33. Stowell SR, Karmakar S, Arthur CM et al. Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane. Mol Biol Cell 2009;20:1408-18.
34. Dillon SR, Constantinescu A, Schlissel MS. Annexin-V binds to positively selected B cells. J Immunol 2001;166:58-71.
35. Elliott JI, Surprenant A, Marelli-Berg FM et al. Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 2005;7:808-16.
36. Dias-Baruffi M, Zhu H, Cho M et al. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J Biol Chem 2003;278:41282-93.
37. Balasubramanian K, Mirnikjoo B, Schroit AJ. Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J Biol Chem 2007;282:18357-64.
38. Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 1991;51:3062-6.
39. Connor J, Bucana C, Fidler IJ, Schroit AJ. Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation. Proc Natl Acad Sci U S A 1989;86:3184-8.
40. Sugimura M, Donato R, Kakkar VV, Scully MF. Annexin-V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces. Blood Coagul Fibrinolysis 1994;5:365-73.
41. Rao LV, Tait JF, Hoang AD. Binding of Annexin-V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res 1992;67:517-31.
42. Woehlecke H, Pohl A, Alder-Baerens N, Lage H, Herrmann A. Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2). Biochem J 2003;376:489-95.
43. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-88.
44. Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett 2008;267:204-15.
45. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:935-50.
46. Dong HP, Elstrand MB, Holth A et al. NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol 2006;125:451-8.
47. Witowski J, Ksiazek K, Jorres A. New insights into the biology of peritoneal mesothelial cells: the roles of epithelial-to-mesenchymal transition and cellular senescence. Nephron Exp Nephrol 2008;108:e69-73.